Business Context and Reporting Period
Company: Zimmer Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 30, 2014
Reporting Period: Fourth quarter and full year ended December 31, 2013.
This filing serves to report the company's results of operations for the specified period. The detailed earnings release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide specific numerical values for revenue, net earnings, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibit 99.1 (Press Release) but are not explicitly stated in the body of this Form 8-K.
Non-GAAP Measures Discussed: The company utilizes two primary types of non-GAAP measures:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Operating Performance: Adjusted net earnings and diluted EPS excluding specific one-time or non-recurring items.
Material Changes and Adjustments
The filing details specific adjustments made to GAAP figures to derive non-GAAP metrics for the fourth quarter and full year 2013, as well as for comparative 2012 periods. These adjustments exclude:
- Inventory step-up and other inventory/manufacturing related charges.
- Special items including acquisition and integration costs, asset impairment charges from prior acquisitions, employee termination benefits, consulting fees, litigation matters, and restructuring costs.
- 2013 Specific: A provision for known and anticipated claims relating to the Durom Acetabular Component.
- 2012 Specific: In addition to the above, a goodwill impairment charge related to the U.S. Spine business and certain tax adjustments.
Guidance, Outlook, and Risks
Guidance: The filing notes that the attached earnings release includes projected adjusted diluted EPS for the full year 2014, though the specific projection value is not listed in this text.
Management Commentary: Management states that these non-GAAP measures are used internally to evaluate business performance, identify operating trends masked by special items, and serve as metrics for incentive compensation programs.
Risks and Contingencies: The filing highlights specific contingencies impacting financial results, including:
- Claims related to the Durom Acetabular Component.
- Asset impairment charges (specifically U.S. Spine goodwill in 2012).
- Global restructuring and operational excellence initiatives.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP financial figures (Revenue, EPS, Cash Flow).
- Verify the reconciliation between GAAP and non-GAAP measures provided in the press release.
- Confirm the specific projected adjusted diluted EPS for 2014 mentioned in the press release.
- Assess the magnitude of the provision for Durom Acetabular Component claims and its impact on net earnings.
- Examine the details of the global restructuring and operational excellence initiatives for future cost implications.